Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
After the surge in sales that cough, cold and allergy (hay fever) remedies experienced in 2022, demand is waning in 2023, with the category recording more subdued growth rates. Traditionally, sales of cough, cold and allergy (hay fever) remedies in…
During the winters 2020/2021 and 2021/2022, the circulation of cough, cold and flu viruses was limited by the restrictions implemented to contain the COVID-19 pandemic. Winter 2022/2023 was the first one with no restrictions in place at all and this…
Cough, cold and allergy (hay fever) sales are expected to be slightly down in 2023. This is partly a result of the very strong performance seen in the previous year, as the lifting of COVID-19 related restrictions led to greater social contact and…
Cough, cold, and allergy (hay fever) remedies is projected to continue to post retail current value growth in 2023, following a severe decline in 2020 due to the Coronavirus (COVID-19) pandemic. Having passed the 2019 pre-pandemic level in 2022, the…
Cough, cold and allergy (hay fever) remedies remains the largest OTC category in Norway, accounting for more than one-third of total OTC value sales in 2023. Despite the already relatively high penetration of these products, the category registered…